Kumquat Biosciences

Kumquat Biosciences is identifying small molecules that can be used to treat cancer by stimulating tumor-specific immune responses. By bringing together an accomplished team and distinguished scientific founder with a proven track record of innovative oncology drug development, Kumquat is focusing on translating breakthrough science into first-in-class therapeutics. Currently, Kumquat is using their immuno-oncology platform to discover new clinical candidates and is collaborating with Eli Lilly to progress toward commercialization.